Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 8/20 | 0.50 |
| ▸ | ACE2 | Q9BYF1 | 6/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | F2 | P00734 | 1/20 | 0.48 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9074016 | 1.00 | ACE (0.50) | ACEACE2ATML3MBTL1ALDH1A1 | |
| SCHEMBL9076967 | 0.85 | ACE2 (0.45) | ACEACE2ATML3MBTL1F2 | |
| SCHEMBL9076970 | 0.85 | ACE2 (0.45) | ACEACE2ATML3MBTL1F2 | |
| SCHEMBL9074952 | 0.84 | ACE2 (0.46) | ACEACE2ATML3MBTL1F2 | |
| SCHEMBL9074948 | 0.84 | ACE2 (0.46) | ACEACE2ATML3MBTL1F2 | |
| SCHEMBL7342855 | 0.83 | F2 (0.46) | ACEACE2ATML3MBTL1F2 | |
| SCHEMBL9076347 | 0.83 | F2 (0.46) | ACEACE2ATML3MBTL1F2 | |
| SCHEMBL9074561 | 0.82 | ACE2 (0.42) | ACEACE2ATML3MBTL1F2 | |
| SCHEMBL9074564 | 0.82 | ACE2 (0.42) | ACEACE2ATML3MBTL1F2 | |
| SCHEMBL18064472 | 0.81 | ACE (0.53) | ACEACE2F2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5583146-A | Heterocyclic thrombin inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 1996-12-10 | — | — | US | disclosed |
| EP-0623596-A1 | N-acylpyrrolidines or N-acylpiperidines having a guanidinyl- or amidinyl-substituted side chain as thrombin inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 1994-11-09 | — | — | EP | disclosed |